First Australian Medicinal Cannabis Company to be Issued with Cultivation License [Interview][Transcript]

Guest: Peter Crock

Presenter: Wayne Bucklar

Guest Bio: Peter is an experienced public company senior manager with deep experience in marketing and technology development. In a 28-year career at Nufarm Limited (ASX: NUF), Peter held senior management roles in marketing, business development, and information technology. He led Nufarm’s new technologies division which involved the licensing and commercial development of several new agribusiness technologies. He also project managed the successful integration of newly acquired businesses and has extensive experience working with regulators in Australia and overseas. Since being appointed CEO of Cann Group, Peter has negotiated key collaborations and technology partnerships with a number of organisations, while also playing an instrumental role in helping the company secure the first regulatory licences for both medicinal cannabis research and cultivation to be issued under Australia’s new regulatory system.

Segment overview: In today’s segment, we are joined by Cann Group Limited CEO Peter Crock here to share information about their company as well as discuss the two licenses issued to the company from the Office of Drug Control (ODC). Cann Group has been issued with one medicinal cannabis permit and two cannabis research permits this year, making them the first Australian Medicinal Cannabis company to be issued with cultivation licences for both medicinal supply and research purposes under the Federal Government’s regulatory system. Their research license allows them to facilitate a research program being undertaken with CSIRO to develop unique cannabis extracts and the supply of plant material for manufacturing into medicinal cannabis products for patient use. Their recently issued medicinal cannabis license will allow them to produce Australian grown material for propagation purposes.

Transcript – TBU